Mountain View, CA (PRWEB) July 09, 2015
FusionOps, the leading provider of supply chain analytic applications, today announced FusionOps Pharma, a powerful new analytics suite designed specifically for the pharmaceutical industry. The new cloud solution provides end-to-end supply chain analytics that enable pharmaceutical companies to increase revenue in high growth segments, while reducing cost and decreasing working capital for mature product lines.
Pharmaceutical companies have been facing unprecedented pressure as their branded drugs have lost patent protection while their R&D pipelines have lagged in filling the void. At the same time, biologics and other specialty medications have emerged as key drivers for topline revenue growth. To support these disparate trends, companies are seeking both high product availability for growth products and reduced cost and lower working capital for mature products. Key initiatives such as reducing inventory, increasing agility, improving reliability and driving better product and customer segmentation are top-of-mind for supply chain executives today.
“Pharmaceutical companies need to balance the need for lean, more agile supply chains to meet the reality of lower priced products, while also driving revenue for new high-growth products,” said Allen Jacques, Vice President of Pharmaceutical Analytics at FusionOps. “Now, with FusionOps Pharma, these companies have analytics purpose-built for the pharmaceutical industry that give them the supply chain visibility they need to support product-specific business goals. With supply chain being a critical driver of corporate success, pharmaceutical companies now have the solution necessary to achieve both top line and bottom line growth.”
The FusionOps Pharma Advantage
FusionOps Pharma provides end-to-end supply chain visibility and alignment across manufacturing, planning, sales & marketing and procurement to support the following business objectives:
- Segmentation of the supply chain to support both revenue growth and cost reduction
Pharma companies can now segment and manage their different product lines based upon service, agility, and cost objectives. Customers can use analytics to refine their supply chains to support revenue for high growth products while adopting cost reduction strategies for those product lines facing competitive pressure.
FusionOps Pharma provides detailed analysis of gross margin, demand volatility, volume, manufacturing absorption, and service level targets to drive segmentation of product lines and customers.
- Reduces inventory without sacrificing customer service levels
FusionOps Pharma provides advanced inventory analytics to help pharma companies reduce inventory across the supply chain. Companies gain powerful insights into inventory profiles and root cause in order to right-size inventory levels.
Sample reports include worldwide inventory infographics (API, tablet and packaged drugs), inventory aging and expiration metrics, and site-level supply chain performance reporting.
- Improves supply chain agility with end-to-end lead time analysis
FusionOps Pharma’s real-time views of the pharmaceutical supply chain — from API to distribution – enables users to quickly spot bottlenecks and process breaks that lead to opportunities for reduced lead-time and greater agility.
Reports include: Lead time infographics across the supply chain, mean and standard deviation for all key manufacturing, quality and distribution processes, and analytics to prioritize opportunities for improvement.
- Ensures reliability of supply across all markets by identifying and mitigating future risk
Augmenting S&OP processes with a consolidated forward looking view of product flow through the supply chain enables identification and mitigation of shortages, leading to effective tradeoffs.
Analytics include: Forward looking metrics to identify capacity bottlenecks, Demand vs. Supply Projections, On-Time-In-Full root cause analysis, and stockout projections.
“As one of the nation’s largest pharmaceutical distributors, we’re constantly optimizing our supply chain to better serve both our customers and suppliers while reducing cost and improving margins,” said David Guzman, CIO of H.D. Smith. “FusionOps analytics has been essential in giving us the ongoing, critical supply chain intelligence we need to maintain our competitive advantage and leadership position in the market.”
Rapid deployment in the cloud.
Pharmaceutical companies are able to see an immediate impact because FusionOps Pharma is a cloud solution. Customers can easily deploy the solution in weeks not months and years.
FusionOps Pharma is offered as an annual subscription enabling customers to achieve results at a fraction of the cost of traditional enterprise software. There are no large up-front costs or annual services fee, but a very predictable annual subscription that pays for itself.
FusionOps is the leading provider of cloud-based analytics applications for the supply chain. Thousands of users in over 80 countries worldwide rely on the FusionOps suite of cloud applications to maximize their supply chain performance. Unlike BI tools, the FusionOps SaaS applications come pre-populated with supply chain-specific metrics. This eliminates the extensive cost and resources companies spend developing their own applications that can run into the tens of millions of dollars. For more information, visit FusionOps.com.
For more information, contact: